Cargando…
Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics
Objectives: We developed a Korean medicine core outcome set for stroke sequelae (COS-SS-KM) to evaluate the effectiveness and safety of herbal medicine (HM) for stroke sequelae, especially for elderly stroke patients in primary clinics. Methods: We identified previously reported outcomes from a lite...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081499/ https://www.ncbi.nlm.nih.gov/pubmed/35548368 http://dx.doi.org/10.3389/fphar.2022.868662 |
_version_ | 1784702999398973440 |
---|---|
author | Cha, Jiyun Kim, Sungha Kim, Pyung-Wha Lee, Hesol Ko, Mi Mi Jang, Soobin Lee, Myeong Soo |
author_facet | Cha, Jiyun Kim, Sungha Kim, Pyung-Wha Lee, Hesol Ko, Mi Mi Jang, Soobin Lee, Myeong Soo |
author_sort | Cha, Jiyun |
collection | PubMed |
description | Objectives: We developed a Korean medicine core outcome set for stroke sequelae (COS-SS-KM) to evaluate the effectiveness and safety of herbal medicine (HM) for stroke sequelae, especially for elderly stroke patients in primary clinics. Methods: We identified previously reported outcomes from a literature review and defined the list of outcomes and effect modifiers for the core outcome set (COS) questionnaire. Three rounds of modified Delphi consensus exercises with experts were conducted online for suitability assessment, and one round of a modified Delphi consensus exercise with primary clinicians was conducted for feasibility assessment. Results: The review identified 17 outcomes and 16 effect modifiers; moreover, six outcomes and one effect modifier were suggested by the experts. The final COS comprised 8 outcomes and 12 effect modifiers for history taking, and experts listed 13 major symptoms of stroke sequelae for symptom assessment. The clinicians agreed on the feasibility of the COS. Conclusion: This COS will help primary care researchers assess the effectiveness of pharmacotherapy, including HM, for elderly patients with stroke sequelae. Future studies should focus on reflecting the opinions of all stakeholders. |
format | Online Article Text |
id | pubmed-9081499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90814992022-05-10 Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics Cha, Jiyun Kim, Sungha Kim, Pyung-Wha Lee, Hesol Ko, Mi Mi Jang, Soobin Lee, Myeong Soo Front Pharmacol Pharmacology Objectives: We developed a Korean medicine core outcome set for stroke sequelae (COS-SS-KM) to evaluate the effectiveness and safety of herbal medicine (HM) for stroke sequelae, especially for elderly stroke patients in primary clinics. Methods: We identified previously reported outcomes from a literature review and defined the list of outcomes and effect modifiers for the core outcome set (COS) questionnaire. Three rounds of modified Delphi consensus exercises with experts were conducted online for suitability assessment, and one round of a modified Delphi consensus exercise with primary clinicians was conducted for feasibility assessment. Results: The review identified 17 outcomes and 16 effect modifiers; moreover, six outcomes and one effect modifier were suggested by the experts. The final COS comprised 8 outcomes and 12 effect modifiers for history taking, and experts listed 13 major symptoms of stroke sequelae for symptom assessment. The clinicians agreed on the feasibility of the COS. Conclusion: This COS will help primary care researchers assess the effectiveness of pharmacotherapy, including HM, for elderly patients with stroke sequelae. Future studies should focus on reflecting the opinions of all stakeholders. Frontiers Media S.A. 2022-04-25 /pmc/articles/PMC9081499/ /pubmed/35548368 http://dx.doi.org/10.3389/fphar.2022.868662 Text en Copyright © 2022 Cha, Kim, Kim, Lee, Ko, Jang and Lee. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Cha, Jiyun Kim, Sungha Kim, Pyung-Wha Lee, Hesol Ko, Mi Mi Jang, Soobin Lee, Myeong Soo Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics |
title | Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics |
title_full | Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics |
title_fullStr | Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics |
title_full_unstemmed | Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics |
title_short | Development of the Korean Medicine Core Outcome Set for Stroke Sequelae: Herbal Medicine Treatment of Elderly Patients With Stroke Sequelae in Primary Clinics |
title_sort | development of the korean medicine core outcome set for stroke sequelae: herbal medicine treatment of elderly patients with stroke sequelae in primary clinics |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081499/ https://www.ncbi.nlm.nih.gov/pubmed/35548368 http://dx.doi.org/10.3389/fphar.2022.868662 |
work_keys_str_mv | AT chajiyun developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics AT kimsungha developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics AT kimpyungwha developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics AT leehesol developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics AT komimi developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics AT jangsoobin developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics AT leemyeongsoo developmentofthekoreanmedicinecoreoutcomesetforstrokesequelaeherbalmedicinetreatmentofelderlypatientswithstrokesequelaeinprimaryclinics |